NCT00334906View on ClinicalTrials.gov

Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

November 30, 2007

Conditions
Alzheimer's Disease
Interventions
DRUG

memantine HCl

Trial Locations (1)

07311

Forest Laboratories, Jersey City

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY

NCT00334906 - Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease) | Biotech Hunter | Biotech Hunter